Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

GC 301

Next Previous
X
Search
Drug Profile

GC 301

Alternative Names: GC-301

Latest Information Update: 03 May 2024

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator GeneCradle Therapeutics
  • Class Gene therapies
  • Mechanism of Action Alpha-glucosidase replacements; Gene transference
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I/II Glycogen storage disease type II

Most Recent Events

  • 19 Apr 2024 Phase-I/II clinical trials in Glycogen storage disease type II (In children, In adults, In adolescents, In the elderly) in China (IV) (NCT06391736)
  • 02 Jun 2023 Phase-I/II clinical trials in Glycogen storage disease type II (In infants, In neonates) in China (IV) (NCT05793307)
  • 31 Mar 2023 GeneCradle plans a phase I/II trial for Glycogen storage disease type II (In Infants) in China in May 2023 (IV, Injection) (NCT05793307)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top